In murine models of asthma, FOXM1 deletion reduced expression of CCL11 and CCL24 which in turn lead to decreased eosinophil and macrophage recruitment to the lung18, and RCM-1 treatment reduced the concentration of proinflammatory cytokines, such as IL-4, IL-5, IL-13, and IL-3317. Here, FOXM1 is linked to asthma.